📰 Sarcoma Foundation News
Page 7 - Sarcoma Foundation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sarcoma Foundation. Real-time updates on events, politics, business and more.
May 26, 2022
- Patients who responded to afami-cel had longer progression-free survival (median 58 weeks) compared to non-responders (median 12 weeks) -- Responses occurred across subgroups, with greater response
December 15, 2021
Leslie Marie Rowe, age 60, surrounded by her family, went to her Lord and Savior on Dec. 1, 2021, in Jacksonville, Florida.
December 15, 2021
Williams hosted a private screening for friends, family and teammates for his long-awaited documentary "Silverback: The Trent Williams Story."
February 1, 2021
Starving cancer cells of the energy they need to grow could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, according to a new study. Studying human cancer cells and mice, researchers report that a two-drug combination targeting a tumor’s energy sources could prove as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer. Osteosarcoma is the most comm...
January 28, 2021
Two drugs targeting cancer cells’ energy source potentially could replace toxic chemo in osteosarcoma January 26, 2021 SHARE A new study from Washington University School of Medicine in St. Louis suggests that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer. Shown is a cross section of osteosarcoma. (Image: Richa Rathore) An in...
January 26, 2021
E-Mail IMAGE: A new study from Washington University School of Medicine in St. Louis suggests that a two-drug combination targeting a tumors energy sources could be as effective and less toxic than... view more Credit: RICHA RATHORE An innovative approach to treating bone tumors - starving cancer cells of the energy they need to grow - could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, suggests a new study from Washingt...
December 10, 2020
Breweries come together to honor memory of DC beer fixture By Mike Thomas and FOX 5 DC Digital Team Published WASHINGTON (FOX 5 DC) - Ben Tolken was a fixture in the D.C. beer community for more than a decade, and now that same community is honoring his memory by creating and selling a new brew to raise money for a cause near and dear to their hearts. Breweries come together to honor memory of D.C. beer fixture A group of breweries from across the D.C. area are coming together to create...